Clinical Trials

AstraZeneca Highlights Results from the P-III (DUO-E) Study Evaluating Imfinzi for the Treatment of Endometrial Cancer at SGO 2024

AstraZeneca Highlights Results from the P-III (DUO-E) Study Evaluating Imfinzi for the Treatment of Endometrial Cancer at SGO 2024

Shots: The 3-armed P-III (DUO-E) study assesses 1L Imfinzi (durvalumab) + CT (carb...

Asieris Reports the P-III Study Results of APL-1702 for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Asieris Reports the P-III Study Results of APL-1702 for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Shots: Asieris has presented results from the P-III clinical evaluation of APL-170...

GSK Highlights the P-III (RUBY) Trial Results of Jemperli to Treat Endometrial Cancer at Society of Gynecologic Oncology 2024

GSK Highlights the P-III (RUBY) Trial Results of Jemperli to Treat Endometrial Cancer at Society of Gynecologic Oncology 2024

Shots: The P-III (RUBY) study assesses Jemperli + CT (carboplatin-paclitaxel) foll...

Cybin Commences the P-II Clinical Evaluation of CYB004 for Treating Generalized Anxiety Disorder

Cybin Commences the P-II Clinical Evaluation of CYB004 for Treating Generalized Anxiety Disorder

Shots: Following the IND clearance in Jan 2024, Cybin has commenced the P-II PoC t...

Image